Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
For over 45 years, the goal of Asset Management Company has been to partner with visionary entrepreneurs and to help create valuable new companies and important new industries by investing capital in exciting, new, technology-based opportunities. “We have observed the ups and downs of venture capital and the fads and failures in the Valley. So we always took the long view,” says Pitch Johnson, founding partner. As of 2012, Asset Management Company has become a family office. Our focus now is managing the Johnson family investments and supporting a variety of not-for-profit organizations through corporate philanthropy and a family foundation.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2000 | Searchbutton | Series B | 0 |
8/2002 | MicroVention | Series D | 19M |
2/1992 | Metra Biosystems | Venture Round | 0 |
8/2008 | Proteus Digital Health | Series D | 28.6M |
1/2006 | Proteus Digital Health | Series C | 33M |
4/2001 | Corrigo | Venture Round | - |
2/1992 | Metra Biosystems | Venture Round | - |
9/2003 | MicroVention | Series D | 10M |
5/2007 | Sonoma Orthopedics | Series B | 10M |
7/2002 | Chimerix | Series A | 1M |
6/2004 | Proteus Digital Health | Series B | 6.3M |
8/2000 | Skire | Series A | - |
11/1999 | Corrigo | Series A | - |
9/2007 | InteKrin | Debt Financing | 180.7k |
8/2001 | MicroVention Terumo | Series C | 12.5M |
4/2009 | InteKrin | Venture Round | 21.4M |
2/2008 | InteKrin | Debt Financing | 533.4k |
1/2006 | InteKrin | Series A | 75k |
4/2010 | Biomimedica | Debt Financing | 250k |
6/2010 | InteKrin | Venture Round | 2.3M |
1/2007 | InteKrin | Series B | 0 |
8/2008 | InteKrin | Series C | 0 |
12/2004 | BiPar Sciences | Series A | 13M |
4/2007 | Sonoma Orthopedics | Series A | 3M |
5/2000 | Corrigo | Series B | 17.5M |
2/2007 | Chimerix | Series D | 23.1M |
9/2003 | Chimerix | Series B | 3.1M |
8/2009 | Chimerix | Series E | 16.1M |
4/2008 | BiPar Sciences | Series B | 625k |
10/2005 | BiPar Sciences | Debt Financing | 1.3M |
1/2009 | BiPar Sciences | Series C | 20M |
2/2007 | BiPar Sciences | Series B | 35M |
4/2009 | Sonoma Orthopedics | Series C | 12M |
7/2006 | Chimerix | Series C | 1.5M |
6/2010 | InteKrin | Venture Round | 0 |
4/2010 | Biomimedica | Debt Financing | 0 |
8/2009 | Chimerix | Series E | 0 |
4/2009 | Sonoma Orthopedics | Series C | 0 |
4/2009 | InteKrin | Venture Round | 0 |
1/2009 | BiPar Sciences | Series C | 0 |
8/2008 | InteKrin | Series C | 0 |
8/2008 | Proteus Digital Health | Series D | 0 |
4/2008 | BiPar Sciences | Series B | 0 |
2/2008 | InteKrin | Debt Financing | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|